1. Home
  2. IFF vs DGX Comparison

IFF vs DGX Comparison

Compare IFF & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Flavors & Fragrances Inc.

IFF

International Flavors & Fragrances Inc.

HOLD

Current Price

$74.64

Market Cap

18.1B

Sector

Industrials

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$193.73

Market Cap

21.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFF
DGX
Founded
1833
1967
Country
United States
United States
Employees
N/A
57000
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1B
21.0B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
IFF
DGX
Price
$74.64
$193.73
Analyst Decision
Buy
Buy
Analyst Count
12
13
Target Price
$89.09
$214.38
AVG Volume (30 Days)
1.6M
763.5K
Earning Date
05-05-2026
04-21-2026
Dividend Yield
2.32%
1.82%
EPS Growth
N/A
13.78
EPS
0.66
2.24
Revenue
N/A
$11,035,000,000.00
Revenue This Year
N/A
$7.53
Revenue Next Year
$3.11
$3.77
P/E Ratio
$112.76
$86.51
Revenue Growth
N/A
11.78
52 Week Low
$59.14
$164.65
52 Week High
$84.45
$213.50

Technical Indicators

Market Signals
Indicator
IFF
DGX
Relative Strength Index (RSI) 51.04 52.69
Support Level $67.44 $192.76
Resistance Level $75.32 $200.49
Average True Range (ATR) 2.73 3.85
MACD -0.33 0.30
Stochastic Oscillator 33.79 75.37

Price Performance

Historical Comparison
IFF
DGX

About IFF International Flavors & Fragrances Inc.

International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest this business in the future.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: